Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARK: Nasal Steroids for Childhood Obstructive Sleep Apnea
NCT02180672Phase 3Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Sep 2014
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate 0.05% cream in obstructive sleep apnea syndrome (OSAS), sponsored by Children's Hospital of Philadelphia. Started Sep 2014; status: completed.
02
Drugs
fluticasone propionate 0.05% cream
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT02180672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180672.